Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

Carcinoembryonic antigen (CEA) affects tumorigenesis by enhancing tumor cell survival and by inducing tumor angiogenesis. This study aimed to evaluate baseline CEA serum levels to predict bevacizumab-based therapy effect and survival in patients with metastatic colorectal cancer (mCRC). Two hundred...

Descripción completa

Detalles Bibliográficos
Autores principales: Prager, Gerald W, Braemswig, Kira H, Martel, Alexandra, Unseld, Matthias, Heinze, Georg, Brodowicz, Thomas, Scheithauer, Werner, Kornek, Gabriela, Zielinski, Christoph C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317865/
https://www.ncbi.nlm.nih.gov/pubmed/24850362
http://dx.doi.org/10.1111/cas.12451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317865/
https://www.ncbi.nlm.nih.gov/pubmed/24850362
http://dx.doi.org/10.1111/cas.12451

Ejemplares similares